In a 27-year-old woman with epigastric pain, markedly elevated CA-125, pancreatic and splenic calcifications on CT, and CA-19-9 approximately twice the upper limit of normal, what is the appropriate next diagnostic step?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Transvaginal Ultrasound and Upper GI Endoscopy

In this 27-year-old woman with markedly elevated CA-125, pancreatic and splenic calcifications, and modestly elevated CA-19-9, the appropriate next step is transvaginal ultrasound to evaluate for ovarian pathology, followed by upper gastrointestinal endoscopy if a CA-125/CEA ratio suggests a gastrointestinal primary.

Diagnostic Reasoning

The clinical presentation requires careful differentiation between several possibilities:

Ovarian vs. Gastrointestinal Primary

The markedly elevated CA-125 is the dominant finding here and points strongly toward ovarian pathology, as CA-125 is elevated in approximately 85% of advanced ovarian cancer cases 1. However, CA-125 can also be elevated in benign conditions including endometriosis, ovarian cysts, and pelvic inflammatory disease 2.

The modestly elevated CA-19-9 (approximately 2x upper limit) creates diagnostic complexity. While CA-19-9 is primarily associated with pancreaticobiliary malignancies, it can be elevated in ovarian cancer—particularly mucinous subtypes 2. The key is that CA-19-9 and CEA levels help distinguish primary mucinous ovarian tumors from gastrointestinal metastases, with a CA-125/CEA ratio ≤25 suggesting gastrointestinal origin 1.

Imaging Algorithm

  1. Transvaginal ultrasound is the first-line imaging modality for suspected ovarian pathology 1. Look for:

    • Multi-locular cysts
    • Solid papillary projections
    • Irregular internal septations
    • Ascites
    • Large lesion size
  2. Measure CEA levels to calculate the CA-125/CEA ratio 1

  3. If CA-125/CEA ratio ≤25, proceed with upper GI endoscopy (colonoscopy and/or gastroscopy) to exclude gastrointestinal primary 3, 1

  4. CT thorax/abdomen/pelvis for complete staging once the primary site is clarified 1

The Pancreatic and Splenic Calcifications

These calcifications are likely incidental findings rather than the primary pathology. Splenic calcifications can result from prior granulomatous disease, healed infarcts, or benign cysts 4. Pancreatic calcifications in a young woman without jaundice or significant pancreatic symptoms are unlikely to represent active malignancy 5.

Critical caveat: While benign splenic cysts can rarely produce CA-19-9 6, and endometriosis can produce markedly elevated CA-19-9 7, the combination of markedly elevated CA-125 with only modestly elevated CA-19-9 makes ovarian pathology the primary concern.

Common Pitfalls to Avoid

  • Do not assume calcifications equal malignancy in a young patient without obstructive symptoms
  • Do not rely solely on tumor markers for diagnosis—tissue diagnosis is essential 8
  • Do not skip transvaginal ultrasound in favor of CT alone, as ultrasound provides superior characterization of adnexal masses 1
  • Do not forget that IgG4-related disease can cause pancreatic involvement with markedly elevated CA-19-9, though this typically presents with jaundice and older age 9, 10

The ultimate diagnosis requires pathological examination of tissue, preferably from surgical specimen rather than cytology alone 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.